Article Details
Retrieved on: 2023-10-12 21:15:14
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Investigational mRNA CMV Vaccine Ready for Phase 3 Clinical Trial, Based on Results of Phase 2 Safety, Efficacy and Dose-Finding Study. Oct 11, 2023.
Article found on: www.patientcareonline.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here